Hospira Defeats Class Action Over Drug Shortage

Law360, New York (July 2, 2012, 5:08 PM EDT) -- Hospira Inc. was within its rights to halt production of an injectable vitamin supplement, a federal judge said Monday in wiping out a proposed class action brought by a Florida woman who says she’s going blind because the treatment isn’t available.

Jennifer Lacognata sued the pharmaceutical company in April over shortages of a vitamin A medicine known as Aquasol A, which Hospira stopped producing in 2010. But there’s no basis for the case, as it would improperly intrude on Hospira’s business prerogatives, U.S. District Judge James...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Lacognata et al v. Hospira, Inc.


Case Number

8:12-cv-00822

Court

Florida Middle

Nature of Suit

P.I.: Other

Judge

James S. Moody, Jr

Date Filed

April 16, 2012

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.